Product Name: CD79 Antibody [CDLA79a-2]
Species Reactivity: Human
Tested Applications: Flow, IF, WB
Applications: Flow Cytometry (intracellular): 0.5-1 ug/million cells in 0.1mlIF: 0.5-1 ug/ml for 30 min at RT (1) Western blot: 1-2 ug/mlOptimal dilution of the CD79 antibody should be determined by the researcher.
User Note: Optimal dilutions for each application to be determined by the researcher
Predicted Molecular Weight:
Immunogen: Amino acids GTYQDVGSLNIADVQ were used as the immunogen for the CD79 antibody. This sequence is from the cytoplasmic portion of the protein.
Host Species: Mouse
Purification: Protein G affinity chromatography
Physical State: Liquid
CAS NO.: 941685-37-6
Product: Ruxolitinib (S enantiomer)
Buffer: PBS with 0.1 mg/ml BSA and 0.05% sodium azide
Concentration: 0.2 mg/mL
Storage Conditions: Aliquot and Store at -20C. Avoid freez-thaw cycles.
Clonality: Monoclonal
Conjugate: Unconjugated
Alternate Names: B-cell antigen receptor complex-associated protein alpha chain, Ig-alpha, MB-1 membrane glycoprotein, Membrane-bound immunoglobulin-associated protein, Surface IgM-associated protein, CD79a, CD79A, IGA, MB1
Accession NO.:
Protein Ino:
Official Symbol: CD79A
Geneid: 973
Background: A disulphide-linked heterodimer consisting of mb-1 (or CD79a) and B29 (or CD79b) polypeptides, CD79 is non-covalently associated with membrane-bound immunoglobulins on B cells. This complex of mb-1 and B29 polypeptides and immunoglobulin constitute the B cell Ag receptor. CD79a first appears at pre B cell stage, early in maturation, and persists until the plasma cell stage where it is found as an intracellular component. CD79a is found in the majority of acute leukemias of precursor B cell type, in B cell lines, B cell lymphomas, and in some myelomas. It is not present in myeloid or T cell lines.
PubMed ID:http://aac.asm.org/content/35/3/560.abstract
